Home › Companies › ROCKET PHARMACEUTICALS INC. › 2023-2024
Compiled from SEC Form N-PX filings and ROCKET PHARMACEUTICALS INC.’s Form 8-K, filed June 20, 2024 (Item 5.07 on EDGAR). Page generated October 13, 2026.
Meeting of June 13, 2024: 13 items on ROCKET PHARMACEUTICALS INC.’s Form 8-K, filed June 20, 2024: 3 approved · 10 without a stated outcome.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided · This season’s results screens
Explore ROCKET PHARMACEUTICALS INC. in the interactive database Compare manager voting policies
These tallies are ROCKET PHARMACEUTICALS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 20, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Elisabeth Björk, M.D., Ph.D. | 67,603,904 | -- | -- | 4,348,329 | 7,857,537 | 94% | Not verified | — |
| Elect Director: Carsten Boess | 71,383,452 | -- | -- | 568,781 | 7,857,537 | 99.2% | Not verified | — |
| Elect Director: Pedro Granadillo | 51,458,742 | -- | -- | 20,493,491 | 7,857,537 | 72% | Not verified | — |
| Elect Director: Gotham Makker, M.D. | 71,537,718 | -- | -- | 414,515 | 7,857,537 | 99.4% | Not verified | — |
| Elect Director: Fady Malik, M.D., Ph.D. | 71,706,448 | -- | -- | 245,785 | 7,857,537 | 99.6% | Not verified | — |
| Elect Director: Gaurav Shah, M.D. | 71,555,239 | -- | -- | 396,994 | 7,857,537 | 99.4% | Not verified | — |
| Elect Director: David P. Southwell | 71,650,603 | -- | -- | 301,630 | 7,857,537 | 99.5% | Not verified | — |
| Elect Director: Roderick Wong, M.D. | 71,278,861 | -- | -- | 673,372 | 7,857,537 | 99.0% | Not verified | — |
| Elect Director: R. Keith Woods | 69,222,478 | -- | -- | 2,729,755 | 7,857,537 | 96% | Not verified | — |
| Elect Director: Naveen Yalamanchi, M.D. | 63,231,665 | -- | -- | 8,720,568 | 7,857,537 | 88% | Not verified | — |
| 2. Ratification of Appointment of Independent Registered Accounting Firm | 79,704,801 | 88,793 | 16,176 | -- | -- | 99.8% | Approved | — |
| 3. Non-Binding Advisory Vote on the Compensation of the Company's Named Executive Officers | 70,707,935 | 1,134,308 | 109,990 | -- | 7,857,537 | 98% | Approved | — |
| 4. Approval of Increase in Number of Authorized Shares of Common Stock | 79,449,783 | 294,948 | 65,039 | -- | 0 | 99.6% | Approved | — |
Source: ROCKET PHARMACEUTICALS INC., Form 8-K, filed with the SEC on June 20, 2024 — read the filing on EDGAR.
Each item below shows how the 238 asset managers that disclosed a ROCKET PHARMACEUTICALS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 5 wordings of this item as funds reported it.
99.2% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Carsten Boess
ROCKET PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Carsten Boess”): 71,383,452 for, 568,781 withheld, per its Form 8-K filed June 20, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.2% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 83 asset managers below reported 35,390,102 for, 1,892 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,108,213 | 0 | 0 | 0 | For |
| Putnam | 5,976,871 | 0 | 0 | 0 | For |
| BlackRock | 2,919,549 | 0 | 0 | 0 | For |
| State Street | 2,692,737 | 0 | 0 | 284 | For |
| T. Rowe Price | 2,358,649 | 0 | 0 | 0 | For |
| Fidelity | 2,014,695 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,166,523 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 914,951 | 0 | 0 | 0 | For |
| Dimensional | 777,692 | 0 | 0 | 0 | For |
| Hartford | 738,308 | 0 | 0 | 0 | For |
| BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) | 690,270 | 0 | 0 | 0 | For |
| Charles Schwab | 533,083 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 490,732 | 0 | 0 | 0 | For |
| Russell Investments | 451,146 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 345,346 | 0 | 0 | 0 | For |
| BARON SELECT FUNDS | 261,254 | 0 | 0 | 0 | For |
| John Hancock | 188,235 | 0 | 0 | 0 | For |
| Jackson National | 186,757 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 177,805 | 0 | 0 | 0 | For |
| Equitable | 176,576 | 0 | 0 | 0 | For |
| Global X | 164,722 | 0 | 0 | 0 | For |
| Mercer Funds | 159,111 | 0 | 0 | 0 | For |
| TIAA | 158,208 | 0 | 0 | 0 | For |
| Victory Capital | 131,333 | 0 | 0 | 0 | For |
| Northwestern Mutual | 127,142 | 0 | 0 | 0 | For |
Showing the 25 largest of 83 asset managers. See all 83 in the interactive database.
Combines 5 wordings of this item as funds reported it.
99.5% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: David P. Southwell
ROCKET PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: David P. Southwell”): 71,650,603 for, 301,630 withheld, per its Form 8-K filed June 20, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.5% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 83 asset managers below reported 35,389,998 for, 1,996 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,108,213 | 0 | 0 | 0 | For |
| Putnam | 5,976,871 | 0 | 0 | 0 | For |
| BlackRock | 2,919,549 | 0 | 0 | 0 | For |
| State Street | 2,692,633 | 0 | 0 | 388 | For |
| T. Rowe Price | 2,358,649 | 0 | 0 | 0 | For |
| Fidelity | 2,014,695 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,166,523 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 914,951 | 0 | 0 | 0 | For |
| Dimensional | 777,692 | 0 | 0 | 0 | For |
| Hartford | 738,308 | 0 | 0 | 0 | For |
| BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) | 690,270 | 0 | 0 | 0 | For |
| Charles Schwab | 533,083 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 490,732 | 0 | 0 | 0 | For |
| Russell Investments | 451,146 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 345,346 | 0 | 0 | 0 | For |
| BARON SELECT FUNDS | 261,254 | 0 | 0 | 0 | For |
| John Hancock | 188,235 | 0 | 0 | 0 | For |
| Jackson National | 186,757 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 177,805 | 0 | 0 | 0 | For |
| Equitable | 176,576 | 0 | 0 | 0 | For |
| Global X | 164,722 | 0 | 0 | 0 | For |
| Mercer Funds | 159,111 | 0 | 0 | 0 | For |
| TIAA | 158,208 | 0 | 0 | 0 | For |
| Victory Capital | 131,333 | 0 | 0 | 0 | For |
| Northwestern Mutual | 127,142 | 0 | 0 | 0 | For |
Showing the 25 largest of 83 asset managers. See all 83 in the interactive database.
Combines 5 wordings of this item as funds reported it.
99.6% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Fady Malik, M.D., Ph.D.
ROCKET PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Fady Malik, M.D., Ph.D.”): 71,706,448 for, 245,785 withheld, per its Form 8-K filed June 20, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.6% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 83 asset managers below reported 35,390,102 for, 1,892 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,108,213 | 0 | 0 | 0 | For |
| Putnam | 5,976,871 | 0 | 0 | 0 | For |
| BlackRock | 2,919,549 | 0 | 0 | 0 | For |
| State Street | 2,692,737 | 0 | 0 | 284 | For |
| T. Rowe Price | 2,358,649 | 0 | 0 | 0 | For |
| Fidelity | 2,014,695 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,166,523 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 914,951 | 0 | 0 | 0 | For |
| Dimensional | 777,692 | 0 | 0 | 0 | For |
| Hartford | 738,308 | 0 | 0 | 0 | For |
| BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) | 690,270 | 0 | 0 | 0 | For |
| Charles Schwab | 533,083 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 490,732 | 0 | 0 | 0 | For |
| Russell Investments | 451,146 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 345,346 | 0 | 0 | 0 | For |
| BARON SELECT FUNDS | 261,254 | 0 | 0 | 0 | For |
| John Hancock | 188,235 | 0 | 0 | 0 | For |
| Jackson National | 186,757 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 177,805 | 0 | 0 | 0 | For |
| Equitable | 176,576 | 0 | 0 | 0 | For |
| Global X | 164,722 | 0 | 0 | 0 | For |
| Mercer Funds | 159,111 | 0 | 0 | 0 | For |
| TIAA | 158,208 | 0 | 0 | 0 | For |
| Victory Capital | 131,333 | 0 | 0 | 0 | For |
| Northwestern Mutual | 127,142 | 0 | 0 | 0 | For |
Showing the 25 largest of 83 asset managers. See all 83 in the interactive database.
Combines 5 wordings of this item as funds reported it.
99.4% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Gaurav Shah, M.D.
ROCKET PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Gaurav Shah, M.D.”): 71,555,239 for, 396,994 withheld, per its Form 8-K filed June 20, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.4% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 83 asset managers below reported 35,345,998 for, 45,996 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,108,213 | 0 | 0 | 0 | For |
| Putnam | 5,976,871 | 0 | 0 | 0 | For |
| BlackRock | 2,919,549 | 0 | 0 | 0 | For |
| State Street | 2,692,633 | 0 | 0 | 388 | For |
| T. Rowe Price | 2,358,649 | 0 | 0 | 0 | For |
| Fidelity | 2,014,695 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,166,523 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 914,951 | 0 | 0 | 0 | For |
| Dimensional | 777,692 | 0 | 0 | 0 | For |
| Hartford | 738,308 | 0 | 0 | 0 | For |
| BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) | 690,270 | 0 | 0 | 0 | For |
| Charles Schwab | 533,083 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 490,732 | 0 | 0 | 0 | For |
| Russell Investments | 451,146 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 345,346 | 0 | 0 | 0 | For |
| BARON SELECT FUNDS | 261,254 | 0 | 0 | 0 | For |
| John Hancock | 188,235 | 0 | 0 | 0 | For |
| Jackson National | 186,757 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 177,805 | 0 | 0 | 0 | For |
| Equitable | 176,576 | 0 | 0 | 0 | For |
| Global X | 164,722 | 0 | 0 | 0 | For |
| Mercer Funds | 159,111 | 0 | 0 | 0 | For |
| TIAA | 158,208 | 0 | 0 | 0 | For |
| Victory Capital | 131,333 | 0 | 0 | 0 | For |
| Northwestern Mutual | 127,142 | 0 | 0 | 0 | For |
Showing the 25 largest of 83 asset managers. See all 83 in the interactive database.
Combines 5 wordings of this item as funds reported it.
99.4% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Gotham Makker, M.D.
ROCKET PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Gotham Makker, M.D.”): 71,537,718 for, 414,515 withheld, per its Form 8-K filed June 20, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.4% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 83 asset managers below reported 35,345,998 for, 45,996 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,108,213 | 0 | 0 | 0 | For |
| Putnam | 5,976,871 | 0 | 0 | 0 | For |
| BlackRock | 2,919,549 | 0 | 0 | 0 | For |
| State Street | 2,692,633 | 0 | 0 | 388 | For |
| T. Rowe Price | 2,358,649 | 0 | 0 | 0 | For |
| Fidelity | 2,014,695 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,166,523 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 914,951 | 0 | 0 | 0 | For |
| Dimensional | 777,692 | 0 | 0 | 0 | For |
| Hartford | 738,308 | 0 | 0 | 0 | For |
| BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) | 690,270 | 0 | 0 | 0 | For |
| Charles Schwab | 533,083 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 490,732 | 0 | 0 | 0 | For |
| Russell Investments | 451,146 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 345,346 | 0 | 0 | 0 | For |
| BARON SELECT FUNDS | 261,254 | 0 | 0 | 0 | For |
| John Hancock | 188,235 | 0 | 0 | 0 | For |
| Jackson National | 186,757 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 177,805 | 0 | 0 | 0 | For |
| Equitable | 176,576 | 0 | 0 | 0 | For |
| Global X | 164,722 | 0 | 0 | 0 | For |
| Mercer Funds | 159,111 | 0 | 0 | 0 | For |
| TIAA | 158,208 | 0 | 0 | 0 | For |
| Victory Capital | 131,333 | 0 | 0 | 0 | For |
| Northwestern Mutual | 127,142 | 0 | 0 | 0 | For |
Showing the 25 largest of 83 asset managers. See all 83 in the interactive database.
Combines 5 wordings of this item as funds reported it.
88% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Naveen Yalamanchi, M.D.
ROCKET PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Naveen Yalamanchi, M.D.”): 63,231,665 for, 8,720,568 withheld, per its Form 8-K filed June 20, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 88% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 83 asset managers below reported 30,868,921 for, 4,523,073 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,108,213 | 0 | 0 | 0 | For |
| Putnam | 5,976,871 | 0 | 0 | 0 | For |
| BlackRock | 0 | 0 | 0 | 2,919,549 | Withhold |
| State Street | 2,692,737 | 0 | 0 | 284 | For |
| T. Rowe Price | 2,358,649 | 0 | 0 | 0 | For |
| Fidelity | 1,982,922 | 0 | 0 | 31,773 | For |
| JANUS INVESTMENT FUND | 1,166,523 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 914,951 | 0 | 0 | 0 | For |
| Dimensional | 777,692 | 0 | 0 | 0 | For |
| Hartford | 738,308 | 0 | 0 | 0 | For |
| BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) | 690,270 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 0 | 0 | 533,083 | Withhold |
| MUTUAL FUND SERIES TRUST | 490,732 | 0 | 0 | 0 | For |
| Russell Investments | 451,146 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 0 | 0 | 0 | 345,346 | Withhold |
| BARON SELECT FUNDS | 261,254 | 0 | 0 | 0 | For |
| John Hancock | 188,235 | 0 | 0 | 0 | For |
| Jackson National | 186,757 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 177,805 | 0 | 0 | 0 | For |
| Equitable | 79,699 | 0 | 0 | 96,877 | Mixed |
| Global X | 0 | 0 | 0 | 164,722 | Withhold |
| Mercer Funds | 159,111 | 0 | 0 | 0 | For |
| TIAA | 158,208 | 0 | 0 | 0 | For |
| Victory Capital | 131,333 | 0 | 0 | 0 | For |
| Northwestern Mutual | 127,142 | 0 | 0 | 0 | For |
Showing the 25 largest of 83 asset managers. See all 83 in the interactive database.
Combines 5 wordings of this item as funds reported it.
72% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Pedro Granadillo
ROCKET PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Pedro Granadillo”): 51,458,742 for, 20,493,491 withheld, per its Form 8-K filed June 20, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 72% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 83 asset managers below reported 26,568,323 for, 73 against, 8,823,598 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,108,213 | 0 | 0 | 0 | For |
| Putnam | 5,976,871 | 0 | 0 | 0 | For |
| BlackRock | 2,919,549 | 0 | 0 | 0 | For |
| State Street | 2,845 | 0 | 0 | 2,690,176 | Withhold |
| T. Rowe Price | 2,358,649 | 0 | 0 | 0 | For |
| Fidelity | 1,438,580 | 0 | 0 | 576,115 | Mixed |
| JANUS INVESTMENT FUND | 703,551 | 0 | 0 | 462,972 | Mixed |
| HARBOR FUNDS | 49,296 | 0 | 0 | 865,655 | Mixed |
| Dimensional | 0 | 0 | 0 | 777,692 | Withhold |
| Hartford | 738,308 | 0 | 0 | 0 | For |
| BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) | 0 | 0 | 0 | 690,270 | Withhold |
| Charles Schwab | 0 | 0 | 0 | 533,083 | Withhold |
| MUTUAL FUND SERIES TRUST | 490,732 | 0 | 0 | 0 | For |
| Russell Investments | 451,146 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 0 | 0 | 0 | 345,346 | Withhold |
| BARON SELECT FUNDS | 0 | 0 | 0 | 261,254 | Withhold |
| John Hancock | 164,823 | 0 | 0 | 23,412 | Mixed |
| Jackson National | 172,200 | 0 | 0 | 14,557 | Mixed |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 177,805 | Withhold |
| Equitable | 110,286 | 0 | 0 | 66,290 | Mixed |
| Global X | 0 | 0 | 0 | 164,722 | Withhold |
| Mercer Funds | 0 | 0 | 0 | 159,111 | Withhold |
| TIAA | 0 | 0 | 0 | 158,208 | Withhold |
| Victory Capital | 1,964 | 0 | 0 | 129,369 | Withhold |
| Northwestern Mutual | 127,142 | 0 | 0 | 0 | For |
Showing the 25 largest of 83 asset managers. See all 83 in the interactive database.
Combines 5 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: R. Keith Woods
ROCKET PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: R. Keith Woods”): 69,222,478 for, 2,729,755 withheld, per its Form 8-K filed June 20, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 96% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 83 asset managers below reported 28,149,912 for, 7,242,082 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,108,213 | 0 | 0 | 0 | For |
| Putnam | 0 | 0 | 0 | 5,976,871 | Withhold |
| BlackRock | 2,919,549 | 0 | 0 | 0 | For |
| State Street | 2,693,021 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,358,649 | 0 | 0 | 0 | For |
| Fidelity | 1,438,580 | 0 | 0 | 576,115 | Mixed |
| JANUS INVESTMENT FUND | 1,166,523 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 914,951 | 0 | 0 | 0 | For |
| Dimensional | 777,692 | 0 | 0 | 0 | For |
| Hartford | 738,308 | 0 | 0 | 0 | For |
| BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) | 690,270 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 0 | 0 | 533,083 | Withhold |
| MUTUAL FUND SERIES TRUST | 490,732 | 0 | 0 | 0 | For |
| Russell Investments | 451,146 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 345,346 | 0 | 0 | 0 | For |
| BARON SELECT FUNDS | 261,254 | 0 | 0 | 0 | For |
| John Hancock | 188,235 | 0 | 0 | 0 | For |
| Jackson National | 186,757 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 177,805 | 0 | 0 | 0 | For |
| Equitable | 176,576 | 0 | 0 | 0 | For |
| Global X | 164,722 | 0 | 0 | 0 | For |
| Mercer Funds | 159,111 | 0 | 0 | 0 | For |
| TIAA | 158,208 | 0 | 0 | 0 | For |
| Victory Capital | 131,333 | 0 | 0 | 0 | For |
| Northwestern Mutual | 127,142 | 0 | 0 | 0 | For |
Showing the 25 largest of 83 asset managers. See all 83 in the interactive database.
Combines 5 wordings of this item as funds reported it.
99.0% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Roderick Wong, M.D.
ROCKET PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Roderick Wong, M.D.”): 71,278,861 for, 673,372 withheld, per its Form 8-K filed June 20, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.0% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 83 asset managers below reported 35,306,066 for, 85,928 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,108,213 | 0 | 0 | 0 | For |
| Putnam | 5,976,871 | 0 | 0 | 0 | For |
| BlackRock | 2,919,549 | 0 | 0 | 0 | For |
| State Street | 2,692,633 | 0 | 0 | 388 | For |
| T. Rowe Price | 2,358,649 | 0 | 0 | 0 | For |
| Fidelity | 2,014,695 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,166,523 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 914,951 | 0 | 0 | 0 | For |
| Dimensional | 777,692 | 0 | 0 | 0 | For |
| Hartford | 738,308 | 0 | 0 | 0 | For |
| BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) | 690,270 | 0 | 0 | 0 | For |
| Charles Schwab | 533,083 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 490,732 | 0 | 0 | 0 | For |
| Russell Investments | 451,146 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 345,346 | 0 | 0 | 0 | For |
| BARON SELECT FUNDS | 261,254 | 0 | 0 | 0 | For |
| John Hancock | 188,235 | 0 | 0 | 0 | For |
| Jackson National | 186,757 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 177,805 | 0 | 0 | 0 | For |
| Equitable | 176,576 | 0 | 0 | 0 | For |
| Global X | 164,722 | 0 | 0 | 0 | For |
| Mercer Funds | 159,111 | 0 | 0 | 0 | For |
| TIAA | 158,208 | 0 | 0 | 0 | For |
| Victory Capital | 131,333 | 0 | 0 | 0 | For |
| Northwestern Mutual | 127,142 | 0 | 0 | 0 | For |
Showing the 25 largest of 83 asset managers. See all 83 in the interactive database.
Combines 5 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Elisabeth Bjork, M.D., Ph.D.
ROCKET PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Elisabeth Björk, M.D., Ph.D.”): 67,603,904 for, 4,348,329 withheld, per its Form 8-K filed June 20, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 94% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 79 asset managers below reported 32,618,869 for, 2,663,799 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,108,213 | 0 | 0 | 0 | For |
| Putnam | 5,976,871 | 0 | 0 | 0 | For |
| BlackRock | 2,919,549 | 0 | 0 | 0 | For |
| State Street | 55,724 | 0 | 0 | 2,637,297 | Withhold |
| T. Rowe Price | 2,358,649 | 0 | 0 | 0 | For |
| Fidelity | 2,014,695 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,166,523 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 914,951 | 0 | 0 | 0 | For |
| Dimensional | 777,692 | 0 | 0 | 0 | For |
| Hartford | 738,308 | 0 | 0 | 0 | For |
| BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) | 690,270 | 0 | 0 | 0 | For |
| Charles Schwab | 533,083 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 490,732 | 0 | 0 | 0 | For |
| Russell Investments | 451,146 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 345,346 | 0 | 0 | 0 | For |
| BARON SELECT FUNDS | 261,254 | 0 | 0 | 0 | For |
| John Hancock | 188,235 | 0 | 0 | 0 | For |
| Jackson National | 186,757 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 177,805 | 0 | 0 | 0 | For |
| Equitable | 176,576 | 0 | 0 | 0 | For |
| Global X | 164,722 | 0 | 0 | 0 | For |
| Mercer Funds | 159,111 | 0 | 0 | 0 | For |
| TIAA | 158,208 | 0 | 0 | 0 | For |
| Victory Capital | 131,333 | 0 | 0 | 0 | For |
| Northwestern Mutual | 127,142 | 0 | 0 | 0 | For |
Showing the 25 largest of 79 asset managers. See all 79 in the interactive database.
Combines 5 wordings of this item as funds reported it.
99.6% Approved · of votes cast
Description as filed by funds: Approval of an amendment to the Company's Seventh Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock.
ROCKET PHARMACEUTICALS INC.’s own tally for this item (“4. Approval of Increase in Number of Authorized Shares of Common Stock”): 79,449,783 for, 294,948 against — passed, per its Form 8-K filed June 20, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal Four - Approval of Increase in Number of Authorized Shares of Common Stock The Company's stockholders approved an Amendment to the Company's Seventh Amended and Restated Certificate of Incorporation to increase the authorized number of shares of common stock from 120,000,000 shares to 180,…”
Support: 99.6% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 83 asset managers below reported 35,347,994 for, 44,000 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,108,213 | 0 | 0 | 0 | For |
| Putnam | 5,976,871 | 0 | 0 | 0 | For |
| BlackRock | 2,919,549 | 0 | 0 | 0 | For |
| State Street | 2,693,021 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,358,649 | 0 | 0 | 0 | For |
| Fidelity | 2,014,695 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,166,523 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 914,951 | 0 | 0 | 0 | For |
| Dimensional | 777,692 | 0 | 0 | 0 | For |
| Hartford | 738,308 | 0 | 0 | 0 | For |
| BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) | 690,270 | 0 | 0 | 0 | For |
| Charles Schwab | 533,083 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 490,732 | 0 | 0 | 0 | For |
| Russell Investments | 451,146 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 345,346 | 0 | 0 | 0 | For |
| BARON SELECT FUNDS | 261,254 | 0 | 0 | 0 | For |
| John Hancock | 188,235 | 0 | 0 | 0 | For |
| Jackson National | 186,757 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 177,805 | 0 | 0 | 0 | For |
| Equitable | 176,576 | 0 | 0 | 0 | For |
| Global X | 164,722 | 0 | 0 | 0 | For |
| Mercer Funds | 159,111 | 0 | 0 | 0 | For |
| TIAA | 158,208 | 0 | 0 | 0 | For |
| Victory Capital | 131,333 | 0 | 0 | 0 | For |
| Northwestern Mutual | 127,142 | 0 | 0 | 0 | For |
Showing the 25 largest of 83 asset managers. See all 83 in the interactive database.
Combines 12 wordings of this item as funds reported it.
98% Approved · of votes cast
Description as filed by funds: APPROVAL OF THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS, ON A NON-BINDING, ADVISORY BASIS.
ROCKET PHARMACEUTICALS INC.’s own tally for this item (“3. Non-Binding Advisory Vote on the Compensation of the Company's Named Executive Officers”): 70,707,935 for, 1,134,308 against — passed, per its Form 8-K filed June 20, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal Three - Non-Binding Advisory Vote on the Compensation of the Company's Named Executive Officers The Company's stockholders approved, on a non-binding, advisory basis, the compensation of the Company's named executive officers, as disclosed in the 2024 Proxy Statement pursuant to Section 14…”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,108,213 | 0 | 0 | 0 | For |
| Putnam | 5,976,871 | 0 | 0 | 0 | For |
| BlackRock | 2,919,549 | 0 | 0 | 0 | For |
| State Street | 2,693,021 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,358,649 | 0 | 0 | 0 | For |
| Fidelity | 2,014,695 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,166,523 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 914,951 | 0 | 0 | 0 | For |
| Dimensional | 777,692 | 0 | 0 | 0 | For |
| Hartford | 738,308 | 0 | 0 | 0 | For |
| BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) | 690,270 | 0 | 0 | 0 | For |
| Charles Schwab | 533,083 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 490,732 | 0 | 0 | 0 | For |
| Russell Investments | 451,146 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 345,346 | 0 | 0 | 0 | For |
| BARON SELECT FUNDS | 261,254 | 0 | 0 | 0 | For |
| John Hancock | 188,235 | 0 | 0 | 0 | For |
| Jackson National | 186,757 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 177,805 | 0 | 0 | 0 | For |
| Equitable | 176,576 | 0 | 0 | 0 | For |
| Global X | 164,722 | 0 | 0 | 0 | For |
| Mercer Funds | 159,111 | 0 | 0 | 0 | For |
| TIAA | 158,208 | 0 | 0 | 0 | For |
| Victory Capital | 131,333 | 0 | 0 | 0 | For |
| Northwestern Mutual | 127,142 | 0 | 0 | 0 | For |
Fund voting reports, all 81 managers: 35,370,555 for, 20,884 against. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| RTW INVESTMENTS, LP | 14,343,571 | 0 | 0 | 0 | For |
| Wellington | 8,071,272 | 0 | 0 | 0 | For |
| State Street | 3,846,434 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,988,648 | 0 | 0 | 0 | For |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 2,734,755 | 0 | 0 | 0 | For |
| MAVERICK CAPITAL LTD | 2,049,067 | 0 | 0 | 0 | For |
| Janus Henderson | 2,011,815 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 1,499,672 | 0 | 0 | 0 | For |
| Boxer Capital, LLC | 1,466,051 | 0 | 0 | 0 | For |
| BlackRock | 1,399,225 | 0 | 0 | 0 | For |
| PICTET ASSET MANAGEMENT SA | 1,189,815 | 0 | 0 | 0 | For |
| Logos Global Management LP | 1,150,000 | 0 | 0 | 0 | For |
| FRANKLIN ADVISERS INC | 1,115,882 | 0 | 0 | 0 | For |
| Novo Holdings A/S | 1,100,000 | 0 | 0 | 0 | For |
| BAMCO INC /NY/ | 951,524 | 0 | 0 | 0 | For |
| Avidity Partners Management LP | 850,020 | 0 | 0 | 0 | For |
| Putnam | 751,485 | 0 | 0 | 0 | For |
| JPMorgan | 627,137 | 0 | 0 | 0 | For |
| Fidelity | 578,352 | 0 | 0 | 0 | For |
| Charles Schwab | 533,083 | 0 | 0 | 0 | For |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 0 | 418,745 | 0 | 0 | Against |
| TANG CAPITAL MANAGEMENT LLC | 404,707 | 0 | 0 | 0 | For |
| Northern Trust | 347,524 | 56 | 0 | 0 | For |
| Citadel | 342,031 | 0 | 0 | 0 | For |
| ACUTA CAPITAL PARTNERS, LLC | 330,510 | 0 | 0 | 0 | For |
Institutional-manager reports, all 179 managers: 55,139,182 for, 966,046 against, 264 withheld. Showing the 25 largest; see all in the interactive database.
Combines 3 wordings of this item as funds reported it.
99.8% Approved · of votes cast
Description as filed by funds: Ratification of the appointment of EisnerAmper LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.
ROCKET PHARMACEUTICALS INC.’s own tally for this item (“2. Ratification of Appointment of Independent Registered Accounting Firm”): 79,704,801 for, 88,793 against — passed, per its Form 8-K filed June 20, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal Two - Ratification of Appointment of Independent Registered Accounting Firm The Company's stockholders ratified the appointment of EisnerAmper LLP as the Company's independent registered accounting firm for the fiscal year ending December 31, 2024 by the following votes:”
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 82 asset managers below reported 35,390,010 for, 439 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,108,213 | 0 | 0 | 0 | For |
| Putnam | 5,976,871 | 0 | 0 | 0 | For |
| BlackRock | 2,919,549 | 0 | 0 | 0 | For |
| State Street | 2,692,582 | 439 | 0 | 0 | For |
| T. Rowe Price | 2,358,649 | 0 | 0 | 0 | For |
| Fidelity | 2,014,695 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,166,523 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 914,951 | 0 | 0 | 0 | For |
| Dimensional | 777,692 | 0 | 0 | 0 | For |
| Hartford | 738,308 | 0 | 0 | 0 | For |
| BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) | 690,270 | 0 | 0 | 0 | For |
| Charles Schwab | 533,083 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 490,732 | 0 | 0 | 0 | For |
| Russell Investments | 451,146 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 345,346 | 0 | 0 | 0 | For |
| BARON SELECT FUNDS | 261,254 | 0 | 0 | 0 | For |
| John Hancock | 188,235 | 0 | 0 | 0 | For |
| Jackson National | 186,757 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 177,805 | 0 | 0 | 0 | For |
| Equitable | 176,576 | 0 | 0 | 0 | For |
| Global X | 164,722 | 0 | 0 | 0 | For |
| Mercer Funds | 159,111 | 0 | 0 | 0 | For |
| TIAA | 158,208 | 0 | 0 | 0 | For |
| Victory Capital | 131,333 | 0 | 0 | 0 | For |
| Northwestern Mutual | 127,142 | 0 | 0 | 0 | For |
Showing the 25 largest of 82 asset managers. See all 82 in the interactive database.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 90,646,590 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 11.15% |
| 2 | Putnam | 6.59% |
| 3 | BlackRock | 3.22% |
| 4 | State Street | 2.97% |
| 5 | T. Rowe Price | 2.60% |
| 6 | Fidelity | 2.22% |
| 7 | JANUS INVESTMENT FUND | 1.29% |
| 8 | HARBOR FUNDS | 1.01% |
| 9 | Dimensional | 0.86% |
| 10 | Hartford | 0.81% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | RTW INVESTMENTS, LP | 15.82% |
| 2 | Wellington | 8.90% |
| 3 | State Street | 4.24% |
| 4 | T. Rowe Price | 3.30% |
| 5 | WESTFIELD CAPITAL MANAGEMENT CO LP | 3.02% |
| 6 | MAVERICK CAPITAL LTD | 2.26% |
| 7 | Janus Henderson | 2.22% |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 1.65% |
| 9 | Boxer Capital, LLC | 1.62% |
| 10 | BlackRock | 1.54% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| Roderick Wong, M.D. | 20.27% | DEF14A |
| RTW Investments, LP | 20.07% | DEF14A |
| Wellington Management | 10.10% | 13F |
| BlackRock | 7.85% | 13F |
| Vanguard Group | 7.60% | 13F |
| State Street | 4.63% | 13F |
| Morgan Stanley | 4.02% | 13F |
| T. Rowe Price | 3.25% | 13F |
| Gaurav Shah, M.D. | 3.11% | DEF14A |
| Citadel Advisors | 2.79% | 13F |
Percentages above are of 90,646,590 shares outstanding, as reported by ROCKET PHARMACEUTICALS INC. on its Form 10-Q dated March 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from ROCKET PHARMACEUTICALS INC.’s 10-Q dated March 31, 2024. This page is a static snapshot rebuilt weekly on October 13, 2026; a live search always shows the current data.
At ROCKET PHARMACEUTICALS INC.'s shareholder meeting held June 13, 2024, in the 2023-2024 proxy season, 238 asset managers reported how they voted on 13 ballot items in their SEC Form N-PX filings, covering 3,526 separate fund positions. On the most widely held item on that ballot — APPROVAL OF THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS, ON A NON-BINDING… — ROCKET PHARMACEUTICALS INC.'s filing reports the proposal as approved, with 98% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: ROCKET PHARMACEUTICALS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 20, 2024.
ROCKET PHARMACEUTICALS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.
Download data (CSV): ballot items · votes by manager · column guide.